Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

Hanmi Pharmaceutical

4 posts
RRoche
A next-generation obesity treatment that protects muscles while losing weight has raised Hanmi Pharm..
Read More

A next-generation obesity treatment that protects muscles while losing weight has raised Hanmi Pharm..

  • 2026-08-29
Roche Bets Advance Payments Of 262.9 Billion On Phase 1 Clinical SubstancesSecurities Price Target Stock Up, Up To…
RRoche
Chinese Biotech Files World's First Approval Application for 4-1BB Bispecific Antibody Abandoned by Big Pharma — BigGo Finance
Read More

Chinese Biotech Files World’s First Approval Application for 4-1BB Bispecific Antibody Abandoned by Big Pharma — BigGo Finance

  • 2026-08-28
Chinese biotech Leads Biolabs is challenging for the world’s first approval of a 4-1BB-targeting therapy, a target that…
RRoche
Hana Securities raised its target price from 610,000 won to 660,000 won on the 25th, saying it is po..
Read More

Hana Securities raised its target price from 610,000 won to 660,000 won on the 25th, saying it is po..

  • 2026-08-25
사진 확대 [Yonhap News] Hana Securities raised its target price from 610,000 won to 660,000 won on the…
RRoche
Hanmi Pharmaceutical has decided to transfer its technology to "Genentech," a subsidiary of Roche Gr..
Read More

Hanmi Pharmaceutical has decided to transfer its technology to “Genentech,” a subsidiary of Roche Gr..

  • 2026-08-24
Pre-payment without obligation to return KRW 260 billionExcluding Korea, conditions for transfer of copyrights worldwideWill be led by…
Switzerland
www.europesays.com